Sydney Jennings

November 21, 2024

Michael Crotty, MD, an expert in obesity medicine, discusses GLP-1RAs in the context of weight loss, including the novel dual agonist survodutide.

November 21, 2024

Your daily dose of the clinical news you may have missed.

November 20, 2024

The recommendations from WikiGuidelines are the first for UTI prevention, diagnosis, and management in over a decade.

November 20, 2024

Your daily dose of the clinical news you may have missed.

November 19, 2024

William Grady, MD, coauthor of the ECLIPSE clinical trial, discusses the study's rationale, methods, and key findings.

November 19, 2024

The RED-C clinical trial program highlights the promising potential of the rifaximin soluble solid dispersion immediate-release tablets for delaying early HE-related decompensation.

November 15, 2024

Aprocitentan is the first-and-only dual endothelin receptor antagonist approved for the treatment of systemic hypertension.

November 15, 2024

The target action date for the FDA decision is April 18, 2025, according to Sanofi and Regeneron.

November 15, 2024

Your daily dose of the clinical news you may have missed.

November 14, 2024

The CDC just released its annual STD surveillance report. Are you caught up on the latest trends? Try your hand at these 7 questions to find out.